Treatment of Recurrent and Multifocal Central Serous Chorioretinopathy

Brief Summary

The goal of this clinical trial is to learn if subthreshold micropulse laser is a safe, effective, and painless treatment for multifocal and recurrent central serous chorioretinopathy (CSCR) in adults. The main questions it aims to answer are: * Does subthreshold micropulse laser reduce the fluid under the retina, as measured by optical coherence tomography (OCT)? * Does it improve vision and lower the chance of the disease coming back? Participants will: * Have a full eye examination, including vision testing, OCT, and fluorescein angiography before treatment. * Receive subthreshold micropulse laser treatment, which is painless and does not damage the retina. * Return for follow-up visits at 1, 3, and 6 months for vision testing and OCT scans. * Receive a repeat laser session at 3 months if fluid is still present.